Advanced mechanisms in drug delivery
Advanced mechanisms in drug delivery
Impact and assessment of modern mechanisms in drug delivery systems
30-Sep-2015
Europe
$4,950.00
Special Price $3,712.50 save 25 %
Description
Drug delivery refers to the efficient transport of an active pharmaceutical compound to provide a therapeutic effect that is required by the human body. Drug delivery systems are extremely crucial for patients who require regular doses of medication through the prescribed route of administration. The research study deals with drug delivery mechanisms that are categorized as existing and emerging carriers or technologies that deliver the therapeutic at the target site. Drug delivery industry has witnessed a sea change as majority of the conventional carriers such as polymeric micelles, dendrimers and niosomes are being slowly replaced by emerging approaches such as cyclodextrins, microemulsions, hydrogels, etc. due to their ability to improve drug solubility and bioavailability which help the drug cope with the hostile nature of the gastro-intestinal tract. The research study covers the stakeholder analysis of the key players in the drug delivery industry, particularly the drug delivery technology developers and pharmaceutical manufacturers and also assesses the technology adoption with respect to these mechanisms. Finally, opportunity evaluation has been conducted to understand the scope of future mechanisms in drug delivery with the help of a technology roadmap, partnerships model that assess the partnerships based on technology licensing, product development and distribution and the IP landscape that evaluate the level of interest of existing and emerging technologies amongst key stakeholders.
Table of Contents
Research Process Methodology
Research Methodology (continued)
Key Findings
Overview
Technology Roadmap
Polymeric Micelles
Polymeric Micelles
Niosomes
Phosphorous Acids
Starch-Based Carrier
Starch-Based Carrier (continued)
Liposomes
Liposomes (continued)
Microemulsions
Microemulsions (continued)
Magnetic Nanoparticles (MNPs)/ Mesoporous silica systems (MSPs)
Magnetic Nanoparticles (MNPs)
Biodegradable Microstructure Patch Technology
Biodegradable Microstructure Patch Technology (continued)
Cyclodextrins
Cyclodextrins (continued)
Functional Micelles/Biomimetic Microvesicles/Nanosomes
Functional Micelles/Biomimetic Microvesicles/Nanosomes (continued)
Functional Micelles/Biomimetic Microvesicles/NanosomesRecent Innovations (continued)
Supramolecular Architectures
Supramolecular Architectures
Microencapsulated Phase Change Materials
Microencapsulated Phase Change Materials (continued)
Fluid Crystal Nanoparticles/Cholesteric Liquid Crystal/Liquid Crystalline Dendrimers
Fluid Crystal Nanoparticles
Technology Landscape
Demand side Analysis
Stakeholder Analysis
Stakeholder Analysis (continued)
Stakeholder analysis (continued)
SWOT analysis of Key Participants
Funding Assessment
Funding Assessment (continued)
Emerging Technology Roadmap
Emerging Technology Roadmap (continued)
Assessment of Partnerships
Assessment of Partnerships (continued)
Assessment of Partnerships (continued)
Assessment of Partnerships (continued)
Assessment of Partnerships (continued)
Assessment of Partnerships (continued)
Technology Management Strategies
Patent scenario
Patent scenario (continued)
Key contacts
Global Patents
Global Patents (continued)
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Karan Verma |
WIP Number | D6A0-01-00-00-00 |
Is Prebook | No |